ReviewTherapeutic advances in respiratory disease

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience.

Biagio Ricciuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.